The impact of the cancer genome atlas status among patients with recurrent endometrioid endometrial carcinoma treated with secondary cytoreductive surgery

被引:0
|
作者
Abel, Mary Kathryn [1 ]
Velez, Isabela Covelli [1 ]
Reid, Hadley [1 ]
Young, Alexandria [1 ]
Stover, Elizabeth [2 ]
Li, Yvonne [2 ]
Kolin, David [1 ]
Liu, Joyce [2 ]
Feltmate, Colleen [1 ]
St Laurent, Jessica [1 ]
机构
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Dana Farber Canc Inst, Boston, MA USA
关键词
D O I
10.1016/j.ygyno.2024.07.260
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1201
引用
收藏
页码:S177 / S178
页数:2
相关论文
共 50 条
  • [11] Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective study
    Yulan Ren
    Boer Shan
    Daren Shi
    Huaying Wang
    BMC Cancer, 14
  • [12] Outcomes of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
    Gockley, A. A.
    Cronin, A.
    Bookman, M. A.
    Burger, R. A.
    Cristea, M.
    Griggs, J. J.
    Mantia-Smaldone, G. M.
    Meyer, L. A.
    O'Malley, D. M.
    Wright, A. A.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 81 - 82
  • [13] Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data
    Dai, Yibo
    Wang, Zhiqi
    Wang, Jianliu
    GYNECOLOGIC ONCOLOGY, 2020, 158 (01) : 92 - 98
  • [14] Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
    Onda, T
    Yoshikawa, H
    Yasugi, T
    Yamada, M
    Matsumoto, K
    Taketani, Y
    BRITISH JOURNAL OF CANCER, 2005, 92 (06) : 1026 - 1032
  • [15] The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma
    Eisenkop, SM
    Friedman, RL
    Spirtos, NM
    CANCER, 2000, 88 (01) : 144 - 153
  • [16] Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
    T Onda
    H Yoshikawa
    T Yasugi
    M Yamada
    K Matsumoto
    Y Taketani
    British Journal of Cancer, 2005, 92 : 1026 - 1032
  • [17] Impact of optimal secondary cytoreductive surgery on survival outcomes in women with recurrent endometrial carcinoma: A systematic review and meta-analysis
    Raffone, Antonio
    Pellecchia, Giulia
    Pregnolato, Sara
    Raimondo, Diego
    Travaglino, Antonio
    Neola, Daniele
    Driul, Lorenza
    Scambia, Giovanni
    Arcieri, Martina
    Vastarella, Maria Giovanna
    Cobellis, Luigi
    Restaino, Stefano
    Vizzielli, Giuseppe
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025,
  • [18] The impact of secondary cytoreductive surgery in platinum sensitive recurrent ovarian cancer treated with upfront neoadjuvant chemotherapy and interval debulking surgery
    Bizzarri, Nicolo
    Marchetti, Claudia
    Conte, Carmine
    Loverro, Matteo
    Giudice, Maria Teresa
    Quagliozzi, Lorena
    Distefano, Mariagrazia
    Chiantera, Vito
    Scambia, Giovanni
    Fagotti, Anna
    GYNECOLOGIC ONCOLOGY, 2022, 165 (03) : 453 - 458
  • [19] SALVAGE CYTOREDUCTIVE SURGERY FOR PATIENTS WITH RECURRENT ENDOMETRIAL CANCER: WHO WILL GAIN BENEFITS FROM IT?
    Wang, H.
    Ren, Y.
    Shan, B. O. E. R.
    Shi, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [20] Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
    Zang, Rongyu
    Zhu, Jianqing
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 30 (06)